Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0870
+0.0010 (1.16%)
At close: Feb 4, 2026
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 52.98 million as of February 4, 2026. Its market cap has decreased by -52.20% in one year.
Market Cap
52.98M
Enterprise Value
44.33M
Revenue
15.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 52.98M, a decrease of -44.83%. That is a compound annual growth rate of -14.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 52.98M | 14.47% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
| Apr 5, 2022 | 96.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 961.60M |
| Healius | 678.93M |
| Australian Clinical Labs | 530.69M |
| Monash IVF Group | 276.64M |
| Rhythm Biosciences | 62.14M |
| Cryosite | 51.74M |
| INOVIQ | 49.27M |
| BCAL Diagnostics | 42.33M |